194 related articles for article (PubMed ID: 1792963)
1. Towards a neural transplantation therapy for Parkinson's disease: experimental principles from animal studies.
Dunnett SB
Acta Neurochir Suppl (Wien); 1991; 52():35-8. PubMed ID: 1792963
[TBL] [Abstract][Full Text] [Related]
2. Neural transplantation (auto-adrenal, fetal nigral and fetal adrenal) in Parkinson's disease: the Mexican experience.
Madrazo I; Franco-Bourland R; Ostrosky-Solis F; Aguilera M; Cuevas C; Alvarez F; Magallon E; Zamorano C; Morelos A
Prog Brain Res; 1990; 82():593-602. PubMed ID: 1981281
[No Abstract] [Full Text] [Related]
3. Transplantation of fetal mesencephalic tissue in Parkinson's disease.
Freed CR; Breeze RE; Schneck SA
N Engl J Med; 1995 Sep; 333(11):730-1. PubMed ID: 7637761
[No Abstract] [Full Text] [Related]
4. Transplants in Parkinson's disease.
Lindvall O
Eur Neurol; 1991; 31 Suppl 1():17-27. PubMed ID: 1855521
[TBL] [Abstract][Full Text] [Related]
5. Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients.
Cooper O; Astradsson A; Hallett P; Robertson H; Mendez I; Isacson O
J Neurol; 2009 Aug; 256 Suppl 3():310-6. PubMed ID: 19711122
[TBL] [Abstract][Full Text] [Related]
6. [Intracerebral grafts in Parkinson's disease].
Menei P; Guy G; Pouplard-Barthelaix A
Presse Med; 1991 Mar; 20(11):513-7. PubMed ID: 1827190
[TBL] [Abstract][Full Text] [Related]
7. Neuropathology of fetal nigra transplants for Parkinson's disease.
Kordower JH; Sortwell CE
Prog Brain Res; 2000; 127():333-44. PubMed ID: 11142034
[No Abstract] [Full Text] [Related]
8. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.
Kordower JH; Freeman TB; Chen EY; Mufson EJ; Sanberg PR; Hauser RA; Snow B; Olanow CW
Mov Disord; 1998 May; 13(3):383-93. PubMed ID: 9613726
[TBL] [Abstract][Full Text] [Related]
9. Positive potential of fetal nigral implants for Parkinson disease.
Landau WM
Arch Neurol; 2004 Nov; 61(11):1808-9. PubMed ID: 15534196
[No Abstract] [Full Text] [Related]
10. [Transplantation of fetal dopaminergic cells in Parkinson disease].
Zabek M; Mazurowski W; Dymecki J; Stelmachów J; Gawur B; Trautsolt W; Zawada E
Neurol Neurochir Pol; 1992; Suppl 1():13-9. PubMed ID: 1407286
[TBL] [Abstract][Full Text] [Related]
11. Neuropathology of fetal nigral grafts in patients with Parkinson's disease.
Kordower JH; Freeman TB; Olanow CW
Mov Disord; 1998; 13 Suppl 1():88-95. PubMed ID: 9613724
[No Abstract] [Full Text] [Related]
12. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.
Kordower JH; Freeman TB; Snow BJ; Vingerhoets FJ; Mufson EJ; Sanberg PR; Hauser RA; Smith DA; Nauert GM; Perl DP
N Engl J Med; 1995 Apr; 332(17):1118-24. PubMed ID: 7700284
[TBL] [Abstract][Full Text] [Related]
13. Transplantation therapy for Parkinson's disease.
Borlongan CV
Expert Opin Investig Drugs; 2000 Oct; 9(10):2319-30. PubMed ID: 11060809
[TBL] [Abstract][Full Text] [Related]
14. Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell line-derived neurotrophic factor.
Petersen A; Hansson O; Emgård M; Brundin P
Cell Transplant; 2000; 9(5):577-84. PubMed ID: 11144955
[TBL] [Abstract][Full Text] [Related]
15. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts.
Rosenblad C; Martinez-Serrano A; Björklund A
Neuroscience; 1996 Dec; 75(4):979-85. PubMed ID: 8938733
[TBL] [Abstract][Full Text] [Related]
16. Grafting of fetal dopamine neurons in Parkinson's disease. The Czech experience with severe akinetic patients.
Subrt O; Tichy M; Vladyka V; Hurt K
Acta Neurochir Suppl (Wien); 1991; 52():51-3. PubMed ID: 1792967
[TBL] [Abstract][Full Text] [Related]
17. Brain transplant.
Kumar N; Narayanaswamy AS
J Assoc Physicians India; 1994 May; 42(5):403-5. PubMed ID: 7829441
[No Abstract] [Full Text] [Related]
18. Embryonic brain grafts in an animal model of Parkinson's disease. Criteria for human application.
Freed WJ; Cannon-Spoor HE; Wyatt RJ
Appl Neurophysiol; 1984; 47(1-2):16-22. PubMed ID: 6508277
[No Abstract] [Full Text] [Related]
19. Fetal nigral transplantation as a therapy for Parkinson's disease.
Olanow CW; Kordower JH; Freeman TB
Trends Neurosci; 1996 Mar; 19(3):102-9. PubMed ID: 9054056
[TBL] [Abstract][Full Text] [Related]
20. Additive effect of glial cell line-derived neurotrophic factor and neurotrophin-4/5 on rat fetal nigral explant cultures.
Meyer M; Matarredona ER; Seiler RW; Zimmer J; Widmer HR
Neuroscience; 2001; 108(2):273-84. PubMed ID: 11734360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
